SRP-100

N/A

Report date: 2025/10/10 15:32:18
NMEFirst In Class

Base Information

Drug NameSRP-100
Drug Alias NameSerpin Peptide 16 (injectable)SP-16 (injectable)SP-16SRP-100
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulatorsLow density lipoprotein receptor-related protein-1 stimulants
TargetsLow density lipoprotein receptor-related protein-1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)InflammationMyocardial Infarction +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSerpin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSerpin Pharma LlcVirios Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationMyocardial InfarctionPeripheral Nervous System Diseases
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia

Other Information

ATC CodeN/A
Related LinksN/A